Meet the Team

Expert Team with Global Impact
​Spearheaded by a world-class team with profound expertise in key sectors, our company has launched transformative products in global markets, showcasing our leadership in pharmaceutical advancements and market access.
Richard Reavley
Founder, Group CEO
Twenty years of experience building and running SMEs. Extensive C-level experience leading complex M&A transactions, fundraising and business development in multiple global jurisdictions. Seven years capital markets experience at Credit Suisse First Boston and BNP Paribas. Formerly founder and  CEO of Hawkley Oil and Gas, MD of Hallwood Oil and Gas. BSc Chemistry (Hons) from the University of Kent, MBA (Finance) from London Business School.
Dr. Hannah Griffith
Chief Scientific Officer
Seasoned pharmaceutical product development expert with extensive experience developing various dosage forms. Proven ability to navigate complex regulatory landscapes and bring projects to fruition through achievement of market authorisations. PhD from King’s College London in Biochemistry. Former CSO at Veriton Pharma where she took a key product through to a granted license and is named on two patents, former Director of Pharmaceutical Development at MedPharm Ltd where she lead key teams to develop pharmaceutical products for inhalation, topical and ophthalmic routes.
Steve Church
Executive Chairman
Thirty years experience in the UK Pharma industry, including General Management at Cephalon UK and board-level marketing positions with Novo Nordisk and Sanofi. Has led the successful launch of seven major branded pharma products. Most recently, he was an independent consultant to industry majors, advising on product launches and their successful adoption within the NHS. ​​​
Natasha Heer
Supply Chain Director
Twenty years’ Supply Chain experience across multiple industries, ten years in Pharmaceuticals. Successfully delivered numerous transformation projects using Lean principles, Certified Lean Black Belt. Held leadership roles in industry-leading and blue-chip companies such as Veriton Pharma, Honeywell Aerospace and PCI Pharma Services.
Chris Grimes
CEO Green Park Pharma UK
Two decades of international leadership in operational and commercial capacities within the pharmaceutical sector, with twelve years of C-level expertise. Demonstrated expertise in managing the development and distribution of a diverse range of products in multiple global pharma markets. Significant roles at leading pharmaceutical firms such as Veriton Pharma Ltd, Novo Nordisk, UCB Pharma, and Pfizer.
Bill Wild
Finance Director
A Chartered Accountant with 30 years' experience, with a broad range of financial and commercial skills gained at TT Electronics plc, Greenshields JCB and most recently at Veriton Pharma. Since joining Green Park, Bill has worked to establish policies and procedures that will ensure sound financial management of the business and help support the company's future growth.